Lexington, MA, United States of America

Sung Eun Choe

This inventor holds 6 USPTO granted patents and 5 published patent applications and 5 EPO patents. Top assignees: Agios Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, Celgene Corporation. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sung Eun Choe. Retrieved from https://idiyas.com/inventor/sung-eun-choe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 66.7

 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Sung Eun Choe

Introduction

Sung Eun Choe is an accomplished inventor based in Lexington, MA (US). With a total of six patents to his name, he has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment.

Latest Patents

Among his latest patents is a method for treating cancer using trisubstituted benzotriazole derivatives. This invention provides innovative approaches to combat cancer in subjects through the application of these chemical compounds, which are defined by specific formulas and variables.

Career Highlights

Sung Eun Choe has worked with notable companies in the pharmaceutical industry, including Agios Pharmaceuticals, Inc. and Servier Pharmaceuticals LLC. His work in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.

Collaborations

Some of his coworkers include Danielle Ulanet and Bin Wu, who have collaborated with him on various projects, enhancing the scope and impact of his research.

Conclusion

Sung Eun Choe's innovative work and patents reflect his dedication to improving cancer treatment methodologies. His contributions to the pharmaceutical field continue to pave the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…